KEPATUHAN TERHADAP FARMAKOTERAPI SEBAGAI FAKTOR PROGNOSTIK AWAL PADA DIABETES MELITUS TIPE 2: STUDI POTONG LINTANG PERILAKU TERAPI DAN BIOMARKER KREATININ SERUM

Rizal Rizal, Latusuai Leony, Melasari Panduwi Wulan

Abstract


Diabetes Melitus Tipe 2 (DMT2) telah menjadi masalah kesehatan global dan terus meningkat prevalensinya selama satu dekade terakhir, terutama di negara berpenghasilan menengah dan rendah. Hiperglikemia kronis berkontribusi terhadap progresifitas nefropati diabetik melalui berbagai mekanisme seperti pembentukan advanced glycation end (AGEs), stres oksidatif, aktivasi protein kinase C (PKC), serta perubahan hemodinamika intrarenal. Untuk perlindungan terhadap gangguan fungsi ginjal, terapi farmakologis perlu ditaati dalam jangka panjang dan menjadi prasyarat untuk kontrol glikemik guna menghindari terjadinya kerusakan mikrovaskular. Penelitian ini bertujuan untuk menganalisis kepatuhan penggunaan obat anti-diabetes terhadap kreatinin serum yang diindikasikan oleh fungsi ginjal pada pasien DMT2.
Desain penelitian yaitu analitik observasional dengan pendekatan cross-sectional. Sampel diambil menggunakan teknik consecutive sampling pada pasien DM tipe II yang memenuhi kriteria inklusi. Kepatuhan diukur menggunakan kuesioner Diabetes Medication Adherence Scale (DMAS), sedangkan kadar kreatinin serum diperiksa menggunakan metode Jaffe kinetik terkalibrasi. Analisis statistik dilakukan dengan Data dianalisis secara statistik menggunakan uji Chi-Square.
Mayoritas responden menunjukkan tingkat kepatuhan yang bervariasi dengan proporsi tertentu mengalami kadar kreatinin tidak normal. Analisis menunjukkan adanya kecenderungan hubungan antara ketidakpatuhan dan peningkatan kadar kreatinin, meskipun signifikansi statistik bergantung pada batas kemaknaan yang digunakan. Faktor usia, durasi diabetes, dan komorbiditas turut memengaruhi hasil.
Kepatuhan penggunaan obat berpotensi berperan dalam menjaga fungsi ginjal pada pasien DM tipe II. Meskipun desain potong lintang tidak dapat memastikan kausalitas, temuan ini mendukung pentingnya intervensi peningkatan kepatuhan sebagai bagian dari strategi pencegahan komplikasi ginjal pada populasi DM.


Keywords


Diabetes Mellitus Tipe 2; Kepatuhan Obat; Kreatinin Serum; Nefropati Diabetik; Cross-Sectional Studi; Fungsi Ginjal

References


Anakök GA, Awad SF, Çağlayan Ç, Huangfu P, Abu‐Raddad LJ, Ünal B, et al. Impact of Trends and Gender Disparity in Obesity on Future Type 2 Diabetes in Turkey: A Mathematical Modelling Analysis. BMJ Open. 2022. doi:10.1136/bmjopen-2021-053541

Belhadj M, Malek R, Baghous H, Boukheloua M, Arbouche Z, Nouri N, et al. Perspectives of Type 2 Diabetes Mellitus Management in Algeria: A Comprehensive Expert Review. Front Clin Diabetes Healthc. 2025. doi:10.3389/fcdhc.2025.1495849

Leitão Moreira PV, Costa Neta A da, Leite Ferreira FE, de Araújo JM, de Rodrigues RE, Formiga Lima RL, et al. Predicting the Prevalence of Type 2 Diabetes in Brazil: A Modeling Study. Front Public Health. 2024. doi:10.3389/fpubh.2024.1275167

Mohan V, Pradeepa R. Epidemiology of Type 2 Diabetes in India. Indian J Ophthalmol. 2021. doi:10.4103/ijo.ijo_1627_21

Satman İ, Bayirlioglu S, Okumuş F, Erturk N, Yemenici M, CİNEMRE S, et al. Estimates and Forecasts on the Burden of Prediabetes and Diabetes in Adult and Elderly Population in Turkiye. Eur J Epidemiol. 2023. doi:10.1007/s10654-022-00960-8

Fagherazzi G, Sérusclat P, Roux B, Bretin O, Casarotto E, Rabiéga P, et al. Nationwide Trends in Type 1 and Type 2 Diabetes in France (2010–2019): A Population-Based Study Using a Machine Learning Classification Algorithm. Diabetes Ther. 2025. doi:10.1007/s13300-025-01781-0

Cao L, An Y, Liu H, Jiang J, Liu W, Zhou Y, et al. Global Epidemiology of Type 2 Diabetes in Patients With NAFLD or MAFLD: A Systematic Review and Meta-Analysis. BMC Med. 2024. doi:10.1186/s12916-024-03315-0

Hare MJ, Zhao Y, Guthridge S, Burgess P, Barr E, Ellis E, et al. Prevalence and Incidence of Diabetes Among Aboriginal People in Remote Communities of the Northern Territory, Australia: A Retrospective, Longitudinal Data-Linkage Study. BMJ Open. 2022. doi:10.1136/bmjopen-2021-059716

Carlsson S, Andersson T, Jansson S, Nyström T, Rolandsson O, Wei Y. Increasing Incidence of Early-Onset Type 2 Diabetes in Sweden 2006–2021. Eur J Public Health. 2025. doi:10.1093/eurpub/ckaf114

Guo Z, Ji W, Yan M, Zou X, Chen T, Bai F, et al. Global, Regional, and National Burden of Diabetes in Women of Childbearing Age, 1990–2021: A Systematic Analysis From the Global Burden of Disease Study 2021. Front Glob Women Health. 2025. doi:10.3389/fgwh.2025.1528661

Perng W, Conway R, Mayer‐Davis EJ, Dabelea D. Youth-Onset Type 2 Diabetes: The Epidemiology of an Awakening Epidemic. Diabetes Care. 2023. doi:10.2337/dci22-0046

Kaleta M, Leutner M, Thurner S, Endel G, Kiss N, Robausch M, et al. Trends in Diabetes Incidence in Austria 2013–2017. Sci Rep. 2023. doi:10.1038/s41598-023-35806-0

Kibret KT, Backholer K, Peeters A, Tesfay FH, Nichols M. Burdens of Non-Communicable Disease Attributable to Metabolic Risk Factors in Australia, 1990–2019: Joinpoint Regression Analysis of the Global Burden of Disease Study. BMJ Open. 2023. doi:10.1136/bmjopen-2022-071319

Guo JJ, Liu Z, Wang P, Wu H, Fan K, Jin J, et al. Global, Regional, and National Burden Inequality of Chronic Kidney Disease, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021. Front Med. 2025. doi:10.3389/fmed.2024.1501175

Junejo S, Chen M, Ali MU, Ratnam S, Malhotra DV, Gong R. Evolution of Chronic Kidney Disease in Different Regions of the World. J Clin Med. 2025. doi:10.3390/jcm14124144

Ling J, Koye DN, Buizen L, Khunti K, Montvida O, Paul SK. Temporal Trends in Co‐morbidities and Cardiometabolic Risk Factors at the Time of Type 2 Diabetes Diagnosis in The UK. Diabetes Obes Metab. 2021. doi:10.1111/dom.14323

Ladányi E, Salfer B, Balla J, Kárpáti I, Reusz G, Szabó L, et al. Deficiencies in the Recognition and Reporting of Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus; A Hungarian Nationwide Analysis. Int J Public Health. 2023. doi:10.3389/ijph.2023.1606151

Anshari AF, Ichsan B, Cholisoh Z. Hubungan Kepatuhan Minum Obat Terhadap HbA1C Dan Kualitas Hidup Pasien Diabetes Di RSI Purwodadi. JPSCR J Pharm Sci Clin Res. 2023. doi:10.20961/jpscr.v8i3.73753

Firdiawan A, Andayani TM, Kristina SA. Hubungan Kepatuhan Pengobatan Terhadap Outcome Klinik Pasien Diabetes Melitus Tipe 2 Dengan Medication Adherence Rating Scale-5 (MARS-5). Maj Farm. 2021. doi:10.22146/farmaseutik.v17i1.48053

Abenavoli C, Provenzano M, Ksiazek SH, Hu L, Cuna V, Manna GL, et al. Role of Estimated Glomerular Filtration Rate in Clinical Research: The Never-Ending Matter. Rev Cardiovasc Med. 2024. doi:10.31083/j.rcm2501001

Banne A, Era DP, Andrianur F. The Relationship Between Lifestyle and Ureum Creatinine Levels in Chronic Kidney Disease (CKD) Patients at Kudungga Hospital, East Kutai. Formosa J Sci Technol. 2023. doi:10.55927/fjst.v2i9.5944

Duvnjak LS, Božičević S, Lovrenčić MV. Diagnostic Challenges of Diabetic Kidney Disease. Biochem Medica. 2023. doi:10.11613/bm.2023.030501

Jung I, Nam S, Lee DY, Park SY, Yu JH, Seo JA, et al. Association of Succinate and Adenosine Nucleotide Metabolic Pathways With Diabetic Kidney Disease in Patients With Type 2 Diabetes Mellitus. Diabetes Metab J. 2024. doi:10.4093/dmj.2023.0377

Lee CS, Tyagi S, Eileen Koh YL, Gong P, Ang SB, Koh GC, et al. Health Outcomes of Telemonitoring of Patients With Type-2 Diabetes Mellitus: One-Year Results From a Randomized Controlled Trial (Optimizing Care of Patients via Telemedicine in Monitoring and aUgmenting Their Control of Diabetes Mellitus). J Telemed Telecare. 2024. doi:10.1177/1357633x241261733

Tan NC, Tyagi S, Lee CS, Eileen Koh YL, Shawn Goh KL, Gong P, et al. Effectiveness of an Algorithm-Driven Home Telemonitoring System on the Metabolic Control and Self-Care Behaviour of Asian Adults With Type-2 Diabetes Mellitus: A Randomised Controlled Trial. J Telemed Telecare. 2023. doi:10.1177/1357633x231203490

Roddy MK, Mayberry LS, Nair D, Cavanaugh KL. Exploring mHealth Potential to Improve Kidney Function: Secondary Analysis of a Randomized Trial of Diabetes Self-Care in Diverse Adults. BMC Nephrol. 2022. doi:10.1186/s12882-022-02885-6

Provenzano M, Hu L, Abenavoli C, Cianciolo G, Coppolino G, Nicola LD, et al. Estimated Glomerular Filtration Rate in Observational and Interventional Studies in Chronic Kidney Disease. J Nephrol. 2024. doi:10.1007/s40620-024-01887-x

Bartholomae E, Knurick J, Johnston CS. Serum Creatinine as an Indicator of Lean Body Mass in Vegetarians and Omnivores. Front Nutr. 2022. doi:10.3389/fnut.2022.996541

Groothof D, Shehab NBN, Post A, B. Gans RO, L. Bakker SJ, Erler NS. Rounding Creatinine, Cystatin C or Both: Impact on Discordance Group Assignment and GFR-estimating Equation Performance. Nephrol Dial Transplant. 2023. doi:10.1093/ndt/gfad224

khan S, Srinivas Nayak SP, Sen S, Kumar D, Verma VK, Patel D, et al. Diabetic Kidney Disease: Risk Factors, Challenges and Opportunities in the Era of Precision Medicine. Int J Biol Pharm Sci Arch. 2023. doi:10.53771/ijbpsa.2023.5.2.0027

Rizal R, Hariawan H. Efek Antidiabetik Oral Monoterapi dan Kombinasi Terhadap HbA1c pada Pasien Diabetes Melitus Tipe 2 Di Wilayah Kerja Puskesmas Nania Kota Ambon. Vol. 9. 2025;9(1).

Rizal R, Shafiyyah SS. Perbandingan Kadar Serum Kreatinin Dengan Lama Menderita Penyakit pada Pasien Diabetes Melitus. J Kesehat Tambusai. 2024;5(4).

Jo W, Koh ES, Chung S. Therapeutic Roles of Thiazides and Loop Diuretics in Blood Pressure Control and Renal Protection Against Chronic Kidney Disease. Clin Hypertens. 2023. doi:10.1186/s40885-023-00238-5

Ngai A, Baig A, Zia MA, Arca-Contreras K, Haque N, Livetsky V, et al. Comparative Evaluation of ARB Monotherapy and SGLT2/ACE Inhibitor Combination Therapy in the Renal Function of Diabetes Mellitus Patients: A Retrospective, Longitudinal Cohort Study. Int J Mol Sci. 2025. doi:10.3390/ijms26157412

Nielsen SF, Duus CL, Buus NH, Bech JN, Mose FH. Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project). Jmir Res Protoc. 2024. doi:10.2196/56067

Bawazir A, Topf JM, Hiremath S. Protein Restriction in CKD: An Outdated Strategy in the Modern Era. Braz J Nephrol. 2025. doi:10.1590/2175-8239-jbn-2024-po03en

Kesuma S, Eka Farpina EF, Sultan S. Evaluasi Pemeriksaan Kreatinin Dengan Penundaan 12 Jam Pada Pasien Diabetes Melitus. J Sains Dan Kesehat. 2024. doi:10.57151/jsika.v3i1.264

Thanh Tran TT, Ha TY, Phan N, Lê VM, Nguyen HT. Detection of Decline in Estimated Glomerular Filtration Rate in Patients With Type 2 Diabetes by Cystatin C-Based Equations. World J Nephrol. 2024. doi:10.5527/wjn.v13.i4.95761

Syikir M, Suherman S, Astuti A, Niar N, Kiki KS. Diabetes Self Management Education (DSME) Berbasis Health Coaching (HC) Pada Pasien Diabetes Mellitus Type II : Systematic Review. J Pendidik Dan Teknol Kesehat. 2024. doi:10.56467/jptk.v7i1.123

Catanese L, Siwy J, Mischak H, Wendt R, Beige J, Rupprecht H. Recent Advances in Urinary Peptide and Proteomic Biomarkers in Chronic Kidney Disease: A Systematic Review. Int J Mol Sci. 2023. doi:10.3390/ijms24119156




DOI: https://doi.org/10.52447/scpij.v11i2.9459

Refbacks

  • There are currently no refbacks.